mhurhangee/ep-ind-claims huggingface dataset:
An apparatus, comprising: a catheter having a distal portion; an electrode disposed on the distal portion, wherein the electrode has an area that falls within a range of 0.01 - 25 mm 2; a power generator connected to the electrode and configured to apply pulses of radiofrequency power to tissue in contact with the electrode, the pulses having a width of between 10 μs and 100 μs; a temperature sensor at the distal portion for recording temperatures while the pulses are being applied; and a processor operative for computing a rate of change of the temperatures at the distal portion in response to the recorded temperatures and for making an estimate of a thickness of the tissue in response to the rate of change. a catheter having a distal portion; an electrode disposed on the distal portion, wherein the electrode has an area that falls within a range of 0.01 - 25 mm 2; a power generator connected to the electrode and configured to apply pulses of radiofrequency power to tissue in contact with the electrode, the pulses having a width of between 10 μs and 100 μs; a temperature sensor at the distal portion for recording temperatures while the pulses are being applied; and a processor operative for computing a rate of change of the temperatures at the distal portion in response to the recorded temperatures and for making an estimate of a thickness of the tissue in response to the rate of change.
A compound for use in treating proliferative diabetic retinopathy in a patient in need thereof wherein the compound has the structure of Formula: wherein, X is -C(R 9) 2 -O-*, wherein the bond indicated with the asterisk is attached to the phenyl ring; Y is selected from: a) substituted or unsubstituted carbocyclyl, optionally substituted with C 1 -C 4 alkyl, halogen, -OH, or C 1 -C 4 alkoxy; and b) substituted or unsubstituted C 3 -C 10 alkyl, optionally substituted with halogen, -OH, or C 1 -C 4 alkoxy; R 1 is hydrogen and R 2 is hydroxyl; R 7 is hydrogen; R 8 is hydrogen or CH 3; each R 9 is independently hydrogen or substituted or unsubstituted C 1 -C 4 alkyl; each R 33 is independently selected from halogen or substituted or unsubstituted C 1 -C 4 alkyl; and n is 0, 1, or 2; or tautomer, stereoisomer, geometric isomer, N-oxide or a pharmaceutically acceptable salt thereof. X is -C(R 9) 2 -O-*, wherein the bond indicated with the asterisk is attached to the phenyl ring; Y is selected from: a) substituted or unsubstituted carbocyclyl, optionally substituted with C 1 -C 4 alkyl, halogen, -OH, or C 1 -C 4 alkoxy; and b) substituted or unsubstituted C 3 -C 10 alkyl, optionally substituted with halogen, -OH, or C 1 -C 4 alkoxy; a) substituted or unsubstituted carbocyclyl, optionally substituted with C 1 -C 4 alkyl, halogen, -OH, or C 1 -C 4 alkoxy; and b) substituted or unsubstituted C 3 -C 10 alkyl, optionally substituted with halogen, -OH, or C 1 -C 4 alkoxy; R 1 is hydrogen and R 2 is hydroxyl; R 7 is hydrogen; R 8 is hydrogen or CH 3; each R 9 is independently hydrogen or substituted or unsubstituted C 1 -C 4 alkyl; each R 33 is independently selected from halogen or substituted or unsubstituted C 1 -C 4 alkyl;
A method for the production of a polysaccharide fiber whose fiber-forming substance is α(1→3)-glucan, characterized in that the method is a modified viscose process, wherein CS 2 is added to the α(1→3)-glucan-containing sodium hydroxide solution.
A mold for footwear bottoms and other articles composed of two overlapping layers of expandable reticulable polyolefin materials, comprising: - an upper lid provided with cavity for molding a first layer of expandable reticulable polyolefin materials - a lower lid provided with a corresponding cavity for molding a second layer of expandable reticulable polyolefin materials, adapted to be interfaced with said cavity of the upper lid - a plate adapted to be exactly interposed between said two upper and lower lids (1, 2) in such a way to simultaneously close said cavities (10, 20), - said cavity of the upper lid joined with a perimeter channel, - said cavity of the lower lid joined with a perimeter channel, adapted to be exactly interfaced with said channel of the upper lid,, a mold characterized in that: - said intermediate plate is provided on the lower and upper sides with specular ribs (3a, 3b), respectively adapted to be exactly engaged into said channel of the upper lid and said channel of the lower lid. - an upper lid provided with cavity for molding a first layer of expandable reticulable polyolefin materials - a lower lid provided with a corresponding cavity for molding a second layer of expandable reticulable polyolefin materials, adapted to be interfaced with said cavity of the upper lid - a plate adapted to be exactly interposed between said two upper and lower lids (1, 2) in such a way to simultaneously close said cavities (10, 20), - said cavity of the upper lid joined with a perimeter channel, - said cavity of the lower lid joined with a perimeter channel, adapted to be exactly interfaced with said channel of the upper lid,, a mold characterized in that: - said intermediate plate is provided on the lower and upper sides with specular ribs (3a, 3b), respectively adapted to be exactly engaged into said channel of the upper lid and said channel of the lower lid.
An access method in a wireless communications network, comprising: after user equipment UE accesses a non 3rd Generation Partnership Project 3GPP access network, selecting, by a non-3GPP access gateway, a target mobility management network element for the UE, wherein the target mobility management network element supports authentication and authorization functions for the non-3GPP access network; sending, by the non-3GPP access gateway, an authentication and authorization request message to the target mobility management network element, wherein the authentication and authorization request message is used to request to perform authentication and authorization for the UE; after the target mobility management network element successfully performs authentication and authorization for the UE, selecting, by the non-3GPP access gateway, a packet data network gateway P-GW for an access point name APN of the UE; setting up, by the non-3GPP access gateway, a packet data network PDN connection between the non-3GPP access gateway and the selected P-GW for the APN of the UE; and registering, by the non-3GPP access gateway, an identity of the selected P-GW with a home subscriber server HSS by using the target mobility management network element. after user equipment UE accesses a non 3rd Generation Partnership Project 3GPP access network, selecting, by a non-3GPP access gateway, a target mobility management network element for the UE, wherein the target mobility management network element supports authentication and authorization functions for the non-3GPP access network; sending, by the non-3GPP access gateway, an authentication and authorization request message to the target mobility management network element, wherein the authentication and authorization request message is used to request to perform authentication and authorization for the UE; after the target mobility management network element successfully performs authentication and authorization for the UE, selecting, by the non-3GPP access gateway, a packet data network gateway P-GW for an access point name APN of the UE; setting up, by the non-3GPP access gateway, a packet data network PDN connection between the non-3GPP access gateway and the selected P-GW for the APN of the UE; and registering, by the non-3GPP access gateway, an identity of the selected P-GW with a home subscriber server HSS by using the target mobility management network element.
A conductive material with a laminated structure to be used to join terminals (2;5) between two components (1;4), comprising at least a polymer plastic layer, whereby conductive particles are dispersed on the two surfaces of said polymer plastic layer, such that there is no electrical connection in the X and Y directions, said particles being isolated from each other by the polymer plastic layer.
A method of medication management, the method comprising: receiving, at a mobile device, via a network interface from a server, information regarding a medication order; establishing a first near-field communication, NFC, connection between the mobile device and a medication dispensing device; receiving at the mobile device, over the first NFC connection, pairing information from the medication dispensing device for the mobile device to connect to the medication dispensing device; automatically establishing a short range wireless connection, different than first the NFC connection, to wirelessly connect the mobile device to the medication dispensing device using a peer-to-peer pairing process with the pairing information that was received over the first NFC connection; sending, from the mobile device via the short range wireless interface, a medication request including the medication order to the medication dispensing device to initiate dispensing of a medication corresponding to the medication order, the medication request causing the medication dispensing device to provide access to a medication corresponding to the medication order; and sending, with the mobile device via the network interface, dispense information to the server, the dispense information corresponding to the medication provided by the medication dispensing device. receiving, at a mobile device, via a network interface from a server, information regarding a medication order; establishing a first near-field communication, NFC, connection between the mobile device and a medication dispensing device; receiving at the mobile device, over the first NFC connection, pairing information from the medication dispensing device for the mobile device to connect to the medication dispensing device; automatically establishing a short range wireless connection, different than first the NFC connection, to wirelessly connect the mobile device to the medication dispensing device using a peer-to-peer pairing process with the pairing information that was received over the first NFC connection; sending, from the mobile device via the short range wireless interface, a medication request including the medication order to the medication dispensing device to initiate dispensing of a medication corresponding to the medication order, the medication request causing the medication dispensing device to provide access to a medication corresponding to the medication order; and sending, with the mobile device via the network interface, dispense information to the server, the dispense information corresponding to the medication provided by the medication dispensing device.
A non-woven body for binding mercury, comprising a base body made from a non-woven fabric, wherein the base body is doped with gold on the outside and with silver on the inside, the base body comprises an outer ply that encloses the outside and an inner ply that encloses the inside, wherein an electrically neutral intermediate ply is arranged between the outer ply and the inner ply, characterized in that the intermediate ply is doped with carbon nanotubes.
A control device for a charger of electrical battery/batteries of a system, having input terminals intended to be coupled to a charging point, connected to a general supply network providing a main alternating voltage differential, and to said electrical battery via at least lines (L1, L2), characterized in that it includes i) measuring means suitable to be coupled to at least one of said lines (L1, L2) so as to measure at least first and second values of at least one voltage differential which concerns these lines (L1, L2), in the presence respectively of first and second different current consumptions of a set composed of said charger and of said electrical battery, and ii) processing means arranged to force said set (CH, BA) to carry out said first and second current consumptions, then to estimate a parasite impedance existing between said input terminals and said general supply network as a function of said first and second values and said first and second current consumptions, and to determine a value of the charging current of said electrical battery as a function of said estimated parasite impedance, and of said main alternating voltage differential.
Process for the preparation of compound, or pharmaceutically acceptable salt thereof, comprising any of the following steps: step 1) compound formation, via the reaction of 2,3,4-trifluorophenylacetic acid, compound, and 1-cloro-4-iodobutane; step 2) compound (IVa) formation, via chiral resolution of salt formation between a chiral base and compound; step 3) the formation of -6-chloro-2-(2,3,4-trifluorophenyl)hexanoic acid, compound, via dissociation of the compound (IVa) with acid; step 4) the formation of -6-chloro-2-(2,3,4-trifluorophenyl)hexanoyl chloride, compound, via acyl chlorination of compound with chlorinating reagent; step 5) the formation of compound, via coupling reaction between amino-guanidine and the compound; Step 6) compound formation, via intramolecular cyclization of compound in the presence of a base; Step 7) compound formation, via the Sandmeyer reaction. step 1) compound formation, via the reaction of 2,3,4-trifluorophenylacetic acid, compound, and 1-cloro-4-iodobutane; step 2) compound (IVa) formation, via chiral resolution of salt formation between a chiral base and compound; step 3) the formation of -6-chloro-2-(2,3,4-trifluorophenyl)hexanoic acid, compound, via dissociation of the compound (IVa) with acid; step 4) the formation of -6-chloro-2-(2,3,4-trifluorophenyl)hexanoyl chloride, compound, via acyl chlorination of compound with chlorinating reagent; step 5) the formation of compound, via coupling reaction between amino-guanidine and the compound; Step 6) compound formation, via intramolecular cyclization of compound in the presence of a base; Step 7) compound formation,
Electrical device for locking/unlocking a steering column, comprising a latch bolt intended to occupy a locked position of the steering column and a released position of the steering column, with an actuator (2, 3) set into motion by a motor controlling the movement of the latch bolt in the two aforementioned positions of locking and releasing, characterised in that the device further comprises mechanical means for providing the automatic locking of the latch bolt in the locked position of the steering column.
An illumination device comprising: a light diffusion device including element diffusion devices that diffuse incident light; a coherent light source that emits coherent light; a scanner that adjusts a traveling direction of the coherent light so as to allow the coherent light to scan the light diffusion device; and a light condensing optical system that condenses the coherent light such that a spot area on the light diffusion device is smaller than the area of the element diffusion device; wherein: each element diffusion device diffuses the coherent light incident thereon so as to illuminate an element illumination area (Zp) corresponding to the element diffusion device; the illumination device being characterized in that it further comprises: a shaping optical system that shapes the coherent light; wherein: the light condensing optical system is located on a light path of the coherent light from the shaping optical system up to the light diffusion device; and a size (wsx) of the spot area along the direction parallel to a scanning direction (sd) of the spot area is smaller than a half of a size (wsy) of the spot area along the direction orthogonal to the scanning direction (sd) of the spot area. a light diffusion device including element diffusion devices that diffuse incident light; a coherent light source that emits coherent light; a scanner that adjusts a traveling direction of the coherent light so as to allow the coherent light to scan the light diffusion device; and a light condensing optical system that condenses the coherent light such that a spot area on the light diffusion device is smaller than the area of the element diffusion device; wherein: each element diffusion device diffuses the coherent light incident thereon so as to illuminate an element illumination area (Zp) corresponding to the element diffusion device; the illumination device being characterized in that it further comprises: each element diffusion device diffuses the coherent light incident thereon so as to illuminate an element illumination area (Zp) corresponding to the element diffusion device; the illumination device being characterized in that it further comprises: a shaping optical system that shapes the coherent light; wherein: the light condensing optical system is located on a light path of the coherent light from the shaping optical system up to the light diffusion device; and a size (wsx) of the spot area along the direction parallel to a scanning direction (sd) of the spot area is smaller than a half of a size (wsy) of the spot area along the direction orthogonal to the scanning direction (sd) of the spot area. the light condensing optical system is located on a light path of the coherent light from the shaping optical system up to the light diffusion device; and a size (wsx) of the spot area along the direction parallel to a scanning direction (sd) of the spot area is smaller than a half of a size (wsy) of the spot area along the direction orthogonal to the scanning direction (sd) of the spot area.
A cutting tool, comprising: a base member; and a hard coating, said hard coating comprising two first crystalline phases; and a second crystalline phase disposed between said two first crystalline phases, wherein said two first crystalline phases each include, independently, a laminate structure having a Ti 1-x1 Al x1 N phase having a sodium chloride-type crystal structure, and an Al x2 Ti 1-x2 N phase having a sodium chloride-type crystal structure that are alternately stacked, an Al composition ratio x1 of said Ti 1-x1 Al x1 N phase satisfies a relationship 0.5 ≤ x1 ≤ 0.75, an Al composition ratio x2 of said Al x2 Ti 1-x2 N phase satisfies a relationship 0.75 < x2 ≤ 0.95, said laminate structure includes a region in which an Al concentration periodically changes along a stacking direction of said Ti 1-x1 Al x1 N phase and said Al x2 Ti 1-x2 N phase, in said region, a difference between a maximum value of said Al composition ratio x2 and a minimum value of said Al composition ratio x1 is greater than 0.25, and said second crystalline phase contains AIN having a wurtzite-type crystal structure. a base member; and a hard coating, said hard coating comprising two first crystalline phases; and a second crystalline phase disposed between said two first crystalline phases, wherein said two first crystalline phases each include, independently, a laminate structure having a Ti 1-x1 Al x1 N phase having a sodium chloride-type crystal structure, and an Al x2 Ti 1-x2 N phase having a sodium chloride-type crystal structure that are alternately stacked, an Al composition ratio x1 of said Ti 1-x1 Al x1 N phase satisfies a relationship 0.5 ≤ x1 ≤ 0.75, an Al composition ratio x2 of said Al x2 Ti 1-x2 N phase satisfies a relationship 0.75 < x2 ≤ 0.95, said laminate structure includes a region in which an Al concentration periodically changes along a stacking direction of said Ti 1-x1 Al x1 N phase and said Al x2 Ti 1-x2 N phase, in said region, a difference between a maximum value of said Al composition ratio x2 and a minimum value of said Al composition ratio x1 is greater than 0.25, and said second crystalline phase contains AIN having a wurtzite-type crystal structure.
A method for the purification of a crude D-1-deoxygalactonojirimycin contaminated with alkali- or alkali earth metal-containing compound comprising: (a) admixing D-1-deoxygalactonojirimiycin,-with a solution having at least 35% hydrochloric acid or with hydrochloric gas to saturation; (b) removing the chloride salt of the alkali- or alkali earth compound wherein the chloride salt is a solid; and (c) crystallizing the D-1-deoxygalactonojirimycin by addition of a solvent miscible with hydrochloric acid. (a) admixing D-1-deoxygalactonojirimiycin,-with a solution having at least 35% hydrochloric acid or with hydrochloric gas to saturation; (b) removing the chloride salt of the alkali- or alkali earth compound wherein the chloride salt is a solid; and (c) crystallizing the D-1-deoxygalactonojirimycin by addition of a solvent miscible with hydrochloric acid.
A method for producing a hetero type monodispersed polyethylene glycol having functional groups different from each other at both terminals thereof, comprising a compound, which is represented by the following formula: NH 2 -(CH 2 CH 2 O) a -CH 2 CH 2 COOH wherein, in the formula, a represents an integer from 6 to 40; the method comprising: step A of obtaining a compound represented by the following formula by Michael addition reaction of a compound represented by the following formula with a compound represented by the following formula under temperature condition of 5°C or less: TsO-(CH 2 CH 2 O) a -H wherein, in the formula, Ts represents a tosyl group, and a represents an integer from 6 to 40, wherein, in the formula, R 1 represents a hydrocarbon group having from 1 to 6 carbon atoms, TsO-(CH 2 CH 2 O) a -CH 2 CH 2 -COOR 1 wherein, in the formula, Ts represents a tosyl group, R 1 represents a hydrocarbon group having from 1 to 6 carbon atoms, and a represents an integer from 6 to 40; step B of obtaining a compound represented by the following formula by a reaction of the compound represented by the formula with potassium phthalimide: PI-(CH 2 CH 2 O) a -CH 2 CH 2 -COOR 1 wherein, in the formula, PI represents a phthalimido group, R 1 represents a hydrocarbon group having from 1 to 6 carbon atoms, and a represents an integer from 6 to 40; step C of obtaining a compound represented by the following formula by dephthalimidation of the compound represented by the formula: H 2 N-(CH 2 CH 2 O) a -CH 2 CH 2 -COOR 1 wherein, in the formula, R 1 represents a hydrocarbon group having from 1 to 6 carbon atoms, and a represents an integer from 6 to 40; and step D of obtaining the hetero type monodispersed polyethylene glycol comprising the compound represented by the formula by subjecting a reaction product comprising the compound represented by the formula obtained in the step C to separatory extraction treatment and acid hydrolysis treatment.